Валеология: Здоровье, Болезнь, Выздоровление. 2019; : 17-24
СОВРЕМЕННЫЕ ВОЗМОЖНОСТИ МОЛЕКУЛЯРНОЙ АЛЛЕРГОДИАГНОСТИКИ В ПЕДИАТРИЧЕСКОЙ ПРАКТИКЕ
Аннотация
Знания в области молекулярной диагностики аллергии неуклонно возрастают, а качество совершенствуется. Клиницисты в своей практической деятельности ежедневно сталкиваются с трудностями выбора рационального метода диагностики и интерпретации полученных результатов. В статье описаны основные преимущества метода аллергодиагностики, базирующегося на современных достижениях молекулярной биотехнологии. В основе молекулярной диагностики аллергии лежит выявления наличия антител класса иммуноглобулина E к очищенным и рекомбинантным молекулам, а не к экстрактам аллергенов. Точная и своевременная диагностика IgE-опосредованной сенсибилизации позволит в значительной степени оптимизировать терапевтические меры и элиминационную диету у детей, таким образом улучшить их качество жизни.
Список литературы
1. From the Global Strategy for Asthma Management and Prevention // Global Initiative for Asthma (GINA), 2011. – http://www.ginasthma.org/.
2. Консенсус по детской бронхиальной астме // PRACTALL (Practicall Allergology). – 2010.
3. Намазова-Баранова Л.С. Атопический дерматит у детей: современные клинические рекомендации по диагностике и терапии / Л. С. Намазова-Баранова, А. А. Баранов // Вопросы современной педиатрии. – 2016.- Т. 15 - № 3. - С. 280-291.
4. Балаболкин И. И. Современные аспекты патогенеза и терапии атопического дерматита у детей / И. И. Балаболкин // Педиатрия. - 2015. - № 1. - С. 177-185.
5. C. L. Gray, M. E. Levin, H. J. Zar, et al. Food allergy in South African children with atopic dermatitis // Pediatr Allergy Immunol. – 2014. – Vol. 25 – P. 572-579.
6. Muraro A., Agache I., Clark A., Sheikh A., Roberts G., Akdis C. A., et al. EAACI food allergy and anaphylaxis guidelines: managing patients with food allergy and community. Allergy - 2014 – Vol. 69 – P. 1045–1057.
7. G. Longo, I. Berti, A. W. Burks, et al.IgE-mediated food allergy in children // Lancet. – 2013. – Vol. 382. – P. 1664-1669.
8. Boye J. I. Food allergies in developing and emerging economies: need for comprehensive data on prevalence rates // Clin Transl Allergy. - 2012. – Vol. 2. – P. 25.
9. G. Longo, I. Berti, A. W. Burks, et al.IgE - mediated food allergy in children // Lancet. – 2013. – Vol. 382. – P. 1656-1664.
10. J. S. Alm, J. Swartz, B. Björkstén, et al.An anthroposophic lifestyle and intestinal microflora in infancy // Pediatr Allergy Immunol. – 2012. – Vol. 13. – P. 402-41.
11. Gaspar Â., Santos N., Piedade S., SantaMartaC., Pires G., Sampaio G., Arêde C., BorregoL.M., Morais-Almeida M. One-jear survey of paediatric anaphylaxis in an allergy department Eur Ann Allergy // Clin Immunol. – 2015. – Vol. 47. - P. 197-205.
12. R. Gupta, D. Holdford, L. Bilaver, A. Dyer, J. L. Holl, D. Meltzer The economic impact of childhood food allergy in the United States // JAMA Pediatr. – 2013. - Vol.167 (11) - P. 1026-1031.
13. M. Lindner, When allergies attack // Fortune – 2012. – Vol. 162. – P. 14.
14. Sarinho E, Antunes A., Pastorino A., Ribeiro M., Porto Neto A., Kuschnir F. C., et al. Guia prático de atualização: Departamento de Alergia da SBP. // Clin Immunol. – 2013. – Vol. 47. - P. 200-215.
15. T. Umasunthar, J. Leonardi-Bee, M. Hodes, P. J. Turner, C. Gore, P. Habibi, et al. Заболеваемость пищевой анафилаксией у людей с пищевой аллергией: систематический обзор и метаанализ // Clin Exp Allergy – 2013. – Vol. 43. - P. 1333-1341.
16. http://www.who.int/mediacentre/factsheets/fs307/en/index.html.
17. M. A. Calderón, et al.EAACI: a European Declaration on Immunotherapy, designing the future of allergen specific immunotherapy // Clin.Transl.Allergy – 2012. - Vol. 2 - P. 20.
18. V. Bauchau, S. R. Durham Prevalence and rate of diagnosis of allergic rhinitis in Europe // European Respiratory Journal – nov. 2014. – Vol. 24. – P. 758-764.
19. Лопатин А. С. Эпидемиология аллергического ринита в России и в мире / А. С. Лопатин, Н. Д. Чучуева / /Рос. аллергол. журн. - 2013. – Т. 2. -C. 3-11.
20. Katelaris C. H., Lee B. W., Potter P. C. Prevalence and diversity of allergic rhinitis in regions of the world beyond Europe and North America // Clin Exp Allergy – 2012. – Vol. 42 (2). – P. 186-207.
21. Ellwood P., Asher M. I, Stewart A. W., Ait-Khaled N., Mallol J. Strachan D. and the ISAAC Phase III Time Trends Study Group. The challenges of replicating the methodology between Phases I and III of the ISAAC programmer. Int J Tuberc Lung Dis. – 2012. –Vol. 16 (5). –P. 687-693.
22. N. Krieger, J. C., P. D. Waterman, M. J.Soobader, S. V. Subramanian, R. Carson Choosing area based socioeconomic measures to monitor social inequalities in low birth weight and childhood lead poisoning: the Public Health Disparities Geocoding Project (US) // J. Epidemiol. Community Health – 2015. - Vol. 57 (3). - P. 186-199.
23. Испаева Ж. Б. Аллергические заболевания у детей Республики Казахстан / Ж. Б. Испаева // Сб. тез. 2-й международной конференции «Аллергические болезни у детей». - Алматы, 2000. - С. 5.
24. Нурпеисов Т. Т., Аллергология Казахстана: Успехи и перспективы / Т. Т. Нурпеисов // Вестник КАЗНМУ – 2017. – № 4. - C. 68.
25. Сапарова Л. Т. Распространенность аллергических заболеваний у детей Северо- Казахстанской области / Л. Т. Сапарова, Р. И. Розенсон // КАЗНМУ – 2012. - №3. – С. 75-82.
26. Пампура А. Н. Современные методы аллергодиагностики, применяемые у детей, больных атопическим дерматитом / А. Н. Пампура // Вестник дерматологии и венерологии – 2010. - № 4. – C. 10-16.
27. Ковальчук Л. В. Клиническая иммунология и аллергология с основами общей иммунологии / Л. В. Ковальчук, Л. В. Банковская, Р. Я. Мешкова // М.: ГЭОТАР-Медиа. - 2011. – C.633.
28. Балаболкин И. И. Клиническая аллергология детского возраста с нотложными состояниями / И. И. Балаболкин, В. А. Булгакова // М.: Медицинское информационное агентство. - 2011. – C. 264.
29. Hatzler L., Panetta V., Lau S., Wagner P. et al. Molecular spreading and predictive value of preclinical IgE response to Phleum pratense in children with hay fever // J Allergy Clin Immunol. – 2012. – Vol. 130. - № 4. - P. 894–901.
30. Valenta R. et al. Recombinant allergens for immunoblot diagnosis of tree pollen allergy // J Allergy Clin Immunol. - 1991. - Vol. 88. - P. 889-894.
31. Valenta R., Campana R., Focke-Tejkl M. Vaccine development for allergen-specific immunotherapy based on recombinant allergens and synthetic allergen peptides: Lessons from the past and novel mechanisms of action for the future // J Allergy Clin Immunol. – 2016. – № 2. - Vol. 137. - P. 351-357.
32. Canonica G. W., Ansotegui I. J., Pawankar R., et al. Document de consensus WAO–ARIA–GA2LEN sur le diagnostic allergologique moléculaire, Revue Française // Allergologie. - 2015. - Vol. 55. - P. 2-83.
33. K. S. Fang, M. Vitale, P. Fehlner, T. P. KingcDNA cloning and primary structure of a white-face hornet venom allergen, antigen 5 Proc Natl Acad Sci U S A – 1988. - Vol. 85. - P. 895-899.
34. H. Breiteneder, K. Pettenburger, A. Bito, et al.The gene coding for the major birch pollen allergen Betv 1, is highly homologous to a pea disease resistance response gene // EMBO J – 1989. – Vol. 8. - P. 1935-1938.
35. K. Y. Chua, G. A. Stewart, W. R. Thomas, et al.Sequence analysis of cDNA coding for a major house dust mite allergen, Derp 1. Homology with cysteine proteases // J Exp Med – 1988. - Vol. 167 - P. 175-182.
36. C. Ebner, T. Birkner, R. Valenta, et al.Common epitopes of birch pollen and apples—studies by Western and Northern blot // J Allergy Clin Immunol – 1991. – Vol. 88. – P. 588-594.
37. R. Valenta, M. Duchene, K. Pettenburger, et al.Identification of profilin as a novel pollen allergen; IgE autoreactivity in sensitized individuals // Science – 1991. – Vol. 253. - P. 557-560.
38. R. Valenta, S. Vrtala, C. Ebner, D. Kraft, O. Scheiner Diagnosis of grass pollen allergy with recombinant timothy grass (Phleummmunee) pollen allergens Int Arch // Allergy Immunol – 1992. – Vol. 97. - P. 287-294.
39. R. E. Esch, G. A. Plunkett Immunotherapy preparation guidelines, rules, and regulation Curr // Allergy Asthma Rep –2013. – Vol. 13 – P. 406-4013.
40. M. Jutel, I. Agache, S. Bonini, et al. International Consensus on Allergen Immunotherapy II: mechanisms, standardization, and pharmacoeconomics // J Allergy Clin Immunol. – 2016. –Vol. 137. - P. 358-368.
41. Nilsson O. B., Van Hage M., Grönlund H.: Mammalian-derived respiratory allergens - Implications for diagnosis and therapy of individuals allergic to furry animals. Methods - 2014. – Vol. 66. – P. 86–95.
42. P. M. Matricardi, J. Kleine-Tebbe, H. J. Hoffmann, et al.EAACI Molecular Allergology User's Guide Pediatr // Allergy Immunol. – 2016. – Vol. 27 (suppl 23). - P. 1-250.
43. L. Klimek, H. J. Hoffmann, H. Renz, et al.Diagnostic test allergens used for in vivo diagnosis of allergic diseases are at risk // a European Perspective Allergy – 2015. – Vol. 70. - P. 1329-1331.
44. Hiller R., Laffer S., Harwanegg C. et al. Microarrayed allergen molecules: diagnostic gatekeepers for allergy treatment // FASEB J. – 2002. - Vol.16. - P.414-416
45. C. Lupinek, E. Wollmann, R. Valenta Monitoring Allergen Immunotherapy Effects by Microarray Curr Treat Options Allergy. – 2016. – Vol. 3 - P. 189-203.
46. Melioli G., Bonifazi F., Bonini S. et al. The ImmunoCAP ISAC molecular allergology approach in adult multi-sensitized Italian patients with respiratory symptoms // Clin. Biochem. – 2011. –Vol. 44. –P. 1005-1011.
Valeology: Health - Illnes - recovery. 2019; : 17-24
MODERN POSSIBILITIES OF MOLECULAR ALLERGIES IN PEDIATRIC PRACTICE
Abstract
Knowledge in the field of molecular diagnostics of allergy is steadily increasing, and the quality is improving. Clinicians in their practice daily face the difficulty of choosing a rational way of diagnosis and interpretation of the results. The article describes the main advantages of the way of allergy diagnostics, based on the current achievements of molecular biotechnology. The basis of the molecular diagnosis of allergy lies in detecting the presence of antibodies of the immunoglobulin E class to purified and recombinant molecules, and not to allergen extracts. Accurate and timely diagnosis of IgE- mediated sensitization will greatly optimize therapeutic measures and an elimination diet in children, thus improving their quality of life.
References
1. From the Global Strategy for Asthma Management and Prevention // Global Initiative for Asthma (GINA), 2011. – http://www.ginasthma.org/.
2. Konsensus po detskoi bronkhial'noi astme // PRACTALL (Practicall Allergology). – 2010.
3. Namazova-Baranova L.S. Atopicheskii dermatit u detei: sovremennye klinicheskie rekomendatsii po diagnostike i terapii / L. S. Namazova-Baranova, A. A. Baranov // Voprosy sovremennoi pediatrii. – 2016.- T. 15 - № 3. - S. 280-291.
4. Balabolkin I. I. Sovremennye aspekty patogeneza i terapii atopicheskogo dermatita u detei / I. I. Balabolkin // Pediatriya. - 2015. - № 1. - S. 177-185.
5. C. L. Gray, M. E. Levin, H. J. Zar, et al. Food allergy in South African children with atopic dermatitis // Pediatr Allergy Immunol. – 2014. – Vol. 25 – P. 572-579.
6. Muraro A., Agache I., Clark A., Sheikh A., Roberts G., Akdis C. A., et al. EAACI food allergy and anaphylaxis guidelines: managing patients with food allergy and community. Allergy - 2014 – Vol. 69 – P. 1045–1057.
7. G. Longo, I. Berti, A. W. Burks, et al.IgE-mediated food allergy in children // Lancet. – 2013. – Vol. 382. – P. 1664-1669.
8. Boye J. I. Food allergies in developing and emerging economies: need for comprehensive data on prevalence rates // Clin Transl Allergy. - 2012. – Vol. 2. – P. 25.
9. G. Longo, I. Berti, A. W. Burks, et al.IgE - mediated food allergy in children // Lancet. – 2013. – Vol. 382. – P. 1656-1664.
10. J. S. Alm, J. Swartz, B. Björkstén, et al.An anthroposophic lifestyle and intestinal microflora in infancy // Pediatr Allergy Immunol. – 2012. – Vol. 13. – P. 402-41.
11. Gaspar Â., Santos N., Piedade S., SantaMartaC., Pires G., Sampaio G., Arêde C., BorregoL.M., Morais-Almeida M. One-jear survey of paediatric anaphylaxis in an allergy department Eur Ann Allergy // Clin Immunol. – 2015. – Vol. 47. - P. 197-205.
12. R. Gupta, D. Holdford, L. Bilaver, A. Dyer, J. L. Holl, D. Meltzer The economic impact of childhood food allergy in the United States // JAMA Pediatr. – 2013. - Vol.167 (11) - P. 1026-1031.
13. M. Lindner, When allergies attack // Fortune – 2012. – Vol. 162. – P. 14.
14. Sarinho E, Antunes A., Pastorino A., Ribeiro M., Porto Neto A., Kuschnir F. C., et al. Guia prático de atualização: Departamento de Alergia da SBP. // Clin Immunol. – 2013. – Vol. 47. - P. 200-215.
15. T. Umasunthar, J. Leonardi-Bee, M. Hodes, P. J. Turner, C. Gore, P. Habibi, et al. Zabolevaemost' pishchevoi anafilaksiei u lyudei s pishchevoi allergiei: sistematicheskii obzor i metaanaliz // Clin Exp Allergy – 2013. – Vol. 43. - P. 1333-1341.
16. http://www.who.int/mediacentre/factsheets/fs307/en/index.html.
17. M. A. Calderón, et al.EAACI: a European Declaration on Immunotherapy, designing the future of allergen specific immunotherapy // Clin.Transl.Allergy – 2012. - Vol. 2 - P. 20.
18. V. Bauchau, S. R. Durham Prevalence and rate of diagnosis of allergic rhinitis in Europe // European Respiratory Journal – nov. 2014. – Vol. 24. – P. 758-764.
19. Lopatin A. S. Epidemiologiya allergicheskogo rinita v Rossii i v mire / A. S. Lopatin, N. D. Chuchueva / /Ros. allergol. zhurn. - 2013. – T. 2. -C. 3-11.
20. Katelaris C. H., Lee B. W., Potter P. C. Prevalence and diversity of allergic rhinitis in regions of the world beyond Europe and North America // Clin Exp Allergy – 2012. – Vol. 42 (2). – P. 186-207.
21. Ellwood P., Asher M. I, Stewart A. W., Ait-Khaled N., Mallol J. Strachan D. and the ISAAC Phase III Time Trends Study Group. The challenges of replicating the methodology between Phases I and III of the ISAAC programmer. Int J Tuberc Lung Dis. – 2012. –Vol. 16 (5). –P. 687-693.
22. N. Krieger, J. C., P. D. Waterman, M. J.Soobader, S. V. Subramanian, R. Carson Choosing area based socioeconomic measures to monitor social inequalities in low birth weight and childhood lead poisoning: the Public Health Disparities Geocoding Project (US) // J. Epidemiol. Community Health – 2015. - Vol. 57 (3). - P. 186-199.
23. Ispaeva Zh. B. Allergicheskie zabolevaniya u detei Respubliki Kazakhstan / Zh. B. Ispaeva // Sb. tez. 2-i mezhdunarodnoi konferentsii «Allergicheskie bolezni u detei». - Almaty, 2000. - S. 5.
24. Nurpeisov T. T., Allergologiya Kazakhstana: Uspekhi i perspektivy / T. T. Nurpeisov // Vestnik KAZNMU – 2017. – № 4. - C. 68.
25. Saparova L. T. Rasprostranennost' allergicheskikh zabolevanii u detei Severo- Kazakhstanskoi oblasti / L. T. Saparova, R. I. Rozenson // KAZNMU – 2012. - №3. – S. 75-82.
26. Pampura A. N. Sovremennye metody allergodiagnostiki, primenyaemye u detei, bol'nykh atopicheskim dermatitom / A. N. Pampura // Vestnik dermatologii i venerologii – 2010. - № 4. – C. 10-16.
27. Koval'chuk L. V. Klinicheskaya immunologiya i allergologiya s osnovami obshchei immunologii / L. V. Koval'chuk, L. V. Bankovskaya, R. Ya. Meshkova // M.: GEOTAR-Media. - 2011. – C.633.
28. Balabolkin I. I. Klinicheskaya allergologiya detskogo vozrasta s notlozhnymi sostoyaniyami / I. I. Balabolkin, V. A. Bulgakova // M.: Meditsinskoe informatsionnoe agentstvo. - 2011. – C. 264.
29. Hatzler L., Panetta V., Lau S., Wagner P. et al. Molecular spreading and predictive value of preclinical IgE response to Phleum pratense in children with hay fever // J Allergy Clin Immunol. – 2012. – Vol. 130. - № 4. - P. 894–901.
30. Valenta R. et al. Recombinant allergens for immunoblot diagnosis of tree pollen allergy // J Allergy Clin Immunol. - 1991. - Vol. 88. - P. 889-894.
31. Valenta R., Campana R., Focke-Tejkl M. Vaccine development for allergen-specific immunotherapy based on recombinant allergens and synthetic allergen peptides: Lessons from the past and novel mechanisms of action for the future // J Allergy Clin Immunol. – 2016. – № 2. - Vol. 137. - P. 351-357.
32. Canonica G. W., Ansotegui I. J., Pawankar R., et al. Document de consensus WAO–ARIA–GA2LEN sur le diagnostic allergologique moléculaire, Revue Française // Allergologie. - 2015. - Vol. 55. - P. 2-83.
33. K. S. Fang, M. Vitale, P. Fehlner, T. P. KingcDNA cloning and primary structure of a white-face hornet venom allergen, antigen 5 Proc Natl Acad Sci U S A – 1988. - Vol. 85. - P. 895-899.
34. H. Breiteneder, K. Pettenburger, A. Bito, et al.The gene coding for the major birch pollen allergen Betv 1, is highly homologous to a pea disease resistance response gene // EMBO J – 1989. – Vol. 8. - P. 1935-1938.
35. K. Y. Chua, G. A. Stewart, W. R. Thomas, et al.Sequence analysis of cDNA coding for a major house dust mite allergen, Derp 1. Homology with cysteine proteases // J Exp Med – 1988. - Vol. 167 - P. 175-182.
36. C. Ebner, T. Birkner, R. Valenta, et al.Common epitopes of birch pollen and apples—studies by Western and Northern blot // J Allergy Clin Immunol – 1991. – Vol. 88. – P. 588-594.
37. R. Valenta, M. Duchene, K. Pettenburger, et al.Identification of profilin as a novel pollen allergen; IgE autoreactivity in sensitized individuals // Science – 1991. – Vol. 253. - P. 557-560.
38. R. Valenta, S. Vrtala, C. Ebner, D. Kraft, O. Scheiner Diagnosis of grass pollen allergy with recombinant timothy grass (Phleummmunee) pollen allergens Int Arch // Allergy Immunol – 1992. – Vol. 97. - P. 287-294.
39. R. E. Esch, G. A. Plunkett Immunotherapy preparation guidelines, rules, and regulation Curr // Allergy Asthma Rep –2013. – Vol. 13 – P. 406-4013.
40. M. Jutel, I. Agache, S. Bonini, et al. International Consensus on Allergen Immunotherapy II: mechanisms, standardization, and pharmacoeconomics // J Allergy Clin Immunol. – 2016. –Vol. 137. - P. 358-368.
41. Nilsson O. B., Van Hage M., Grönlund H.: Mammalian-derived respiratory allergens - Implications for diagnosis and therapy of individuals allergic to furry animals. Methods - 2014. – Vol. 66. – P. 86–95.
42. P. M. Matricardi, J. Kleine-Tebbe, H. J. Hoffmann, et al.EAACI Molecular Allergology User's Guide Pediatr // Allergy Immunol. – 2016. – Vol. 27 (suppl 23). - P. 1-250.
43. L. Klimek, H. J. Hoffmann, H. Renz, et al.Diagnostic test allergens used for in vivo diagnosis of allergic diseases are at risk // a European Perspective Allergy – 2015. – Vol. 70. - P. 1329-1331.
44. Hiller R., Laffer S., Harwanegg C. et al. Microarrayed allergen molecules: diagnostic gatekeepers for allergy treatment // FASEB J. – 2002. - Vol.16. - P.414-416
45. C. Lupinek, E. Wollmann, R. Valenta Monitoring Allergen Immunotherapy Effects by Microarray Curr Treat Options Allergy. – 2016. – Vol. 3 - P. 189-203.
46. Melioli G., Bonifazi F., Bonini S. et al. The ImmunoCAP ISAC molecular allergology approach in adult multi-sensitized Italian patients with respiratory symptoms // Clin. Biochem. – 2011. –Vol. 44. –P. 1005-1011.
